Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert S Negrin

Showing results (101-110 of 163) with videos related to

Pageof 17
Sort By:
Blood|January 15, 2020
High-parametric evaluation of human invariant natural killer T cells to delineate heterogeneity in allo- and autoimmunityTom Erkers, Bryan J Xie, Laura J Kenyon, et al.
Blood|February 27, 2026
Regulatory-like FOXP3+Helios+ CD4+ T conventional cells correlate with T cell activation after Orca-T immunotherapyCameron S Bader, Scott Killian, Bettina P Iliopoulou, et al.
Blood|August 9, 2003
Rituximab as adjuvant to high-dose therapy and autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphomaSteven M Horwitz, Robert S Negrin, Karl G Blume, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 11, 2014
Total lymphoid irradiation-antithymocyte globulin conditioning and allogeneic transplantation for patients with myelodysplastic syndromes and myeloproliferative neoplasmsJonathan Benjamin, Saurabh Chhabra, Holbrook E Kohrt, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 21, 2006
High-dose carmustine, etoposide, and cyclophosphamide followed by allogeneic hematopoietic cell transplantation for non-Hodgkin lymphomaLisa Y Law, Sandra J Horning, Ruby M Wong, et al.
Blood|August 28, 2015
MLL leukemia induction by genome editing of human CD34+ hematopoietic cellsCorina Buechele, Erin H Breese, Dominik Schneidawind, et al.
Radiation Research|July 4, 2014
Treatment of 4T1 metastatic breast cancer with combined hypofractionated irradiation and autologous T-cell infusionAlexander Filatenkov, Jeanette Baker, Antonia M Müller, et al.
Blood|June 4, 2008
Long-term remission of Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation from matched sibling donors: a 20-year experience with the fractionated total body irradiation-etoposide regimenGinna G Laport, Joseph C Alvarnas, Joycelynne M Palmer, et al.
JCI Insight|July 8, 2021
Imaging alloreactive T cells provides early warning of organ transplant rejectionToshihito Hirai, Aaron T Mayer, Tomomi W Nobashi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 15, 2009
Salvage allogeneic hematopoietic cell transplantation with fludarabine and low-dose total body irradiation after rejection of first allograftsBoglarka Gyurkocza, Thai M Cao, Rainer F Storb, et al.
Pageof 17

Showing results (101-110 of 163) with videos related to

Sort By:
Pageof 17
Blood|January 15, 2020
High-parametric evaluation of human invariant natural killer T cells to delineate heterogeneity in allo- and autoimmunityTom Erkers, Bryan J Xie, Laura J Kenyon, et al.
Blood|February 27, 2026
Regulatory-like FOXP3+Helios+ CD4+ T conventional cells correlate with T cell activation after Orca-T immunotherapyCameron S Bader, Scott Killian, Bettina P Iliopoulou, et al.
Blood|August 9, 2003
Rituximab as adjuvant to high-dose therapy and autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphomaSteven M Horwitz, Robert S Negrin, Karl G Blume, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 11, 2014
Total lymphoid irradiation-antithymocyte globulin conditioning and allogeneic transplantation for patients with myelodysplastic syndromes and myeloproliferative neoplasmsJonathan Benjamin, Saurabh Chhabra, Holbrook E Kohrt, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 21, 2006
High-dose carmustine, etoposide, and cyclophosphamide followed by allogeneic hematopoietic cell transplantation for non-Hodgkin lymphomaLisa Y Law, Sandra J Horning, Ruby M Wong, et al.
Blood|August 28, 2015
MLL leukemia induction by genome editing of human CD34+ hematopoietic cellsCorina Buechele, Erin H Breese, Dominik Schneidawind, et al.
Radiation Research|July 4, 2014
Treatment of 4T1 metastatic breast cancer with combined hypofractionated irradiation and autologous T-cell infusionAlexander Filatenkov, Jeanette Baker, Antonia M Müller, et al.
Blood|June 4, 2008
Long-term remission of Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation from matched sibling donors: a 20-year experience with the fractionated total body irradiation-etoposide regimenGinna G Laport, Joseph C Alvarnas, Joycelynne M Palmer, et al.
JCI Insight|July 8, 2021
Imaging alloreactive T cells provides early warning of organ transplant rejectionToshihito Hirai, Aaron T Mayer, Tomomi W Nobashi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 15, 2009
Salvage allogeneic hematopoietic cell transplantation with fludarabine and low-dose total body irradiation after rejection of first allograftsBoglarka Gyurkocza, Thai M Cao, Rainer F Storb, et al.
Pageof 17